Home > Insider Trading > Filing (0001579618-15-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Ani Pharmaceuticals Inc	ANIP	Pharmaceutical Preparations (2834)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579618	Tracy Marshbanks	1 South Wacker Drive Suite 3900 Chicago IL 60606		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-12	143,516	$63.00	375,829	No	4	S	Indirect	See Footnote 1
Common Stock	Disposition	2015-03-12	5,978	$63.00	15,656	No	4	S	Indirect	See Footnote 2
Common Stock	Disposition	2015-03-12	58,265	$63.00	152,579	No	4	S	Indirect	See Footnote 3
Common Stock	Disposition	2015-03-12	2,241	$63.00	5,870	No	4	S	Indirect	See Footnote 4

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote 1
No	4	S	Indirect	See Footnote 2
No	4	S	Indirect	See Footnote 3
No	4	S	Indirect	See Footnote 4

Footnotes

1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
2: Held by: FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
3: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
4: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).